Monica E. Millner

Array ( [id] => 6048634 [patent_doc_number] => 20020169137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Regulation of amyloid precursor protein expression by modification of ABC transporter expression or activity' [patent_app_type] => new [patent_app_number] => 10/072621 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25217 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169137.pdf [firstpage_image] =>[orig_patent_app_number] => 10072621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037400 [patent_doc_number] => 06872548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Scaffolded fusion polypeptides and compositions and methods for making the same' [patent_app_type] => utility [patent_app_number] => 10/057890 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 16156 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872548.pdf [firstpage_image] =>[orig_patent_app_number] => 10057890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6689061 [patent_doc_number] => 20030032786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM2' [patent_app_type] => new [patent_app_number] => 10/056884 [patent_app_country] => US [patent_app_date] => 2002-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 120946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032786.pdf [firstpage_image] =>[orig_patent_app_number] => 10056884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377991 [patent_doc_number] => 20020119523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => '67073, a human phospholipid transporter family member and uses therefor' [patent_app_type] => new [patent_app_number] => 10/041395 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42022 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119523.pdf [firstpage_image] =>[orig_patent_app_number] => 10041395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1095662 [patent_doc_number] => 06821750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'ABCG8 vectors, host cells, and method of making' [patent_app_type] => B2 [patent_app_number] => 09/989981 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 3 [patent_no_of_words] => 32833 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821750.pdf [firstpage_image] =>[orig_patent_app_number] => 09989981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071947 [patent_doc_number] => 06841531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Methods and use of motoneuronotrophic factors' [patent_app_type] => utility [patent_app_number] => 09/989481 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 36 [patent_no_of_words] => 12443 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841531.pdf [firstpage_image] =>[orig_patent_app_number] => 09989481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205163 [patent_doc_number] => 06716589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Discordant helix stabilization for prevention of amyloid formation' [patent_app_type] => B2 [patent_app_number] => 09/988842 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 14784 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716589.pdf [firstpage_image] =>[orig_patent_app_number] => 09988842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844312 [patent_doc_number] => 20020132298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => '67118, 67067, and 62092, human proteins and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/002769 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 53894 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132298.pdf [firstpage_image] =>[orig_patent_app_number] => 10002769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536384 [patent_doc_number] => 20020137108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/986471 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137108.pdf [firstpage_image] =>[orig_patent_app_number] => 09986471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986089 [patent_doc_number] => 20020098584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Postmortem stem cells' [patent_app_type] => new [patent_app_number] => 10/012885 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12128 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098584.pdf [firstpage_image] =>[orig_patent_app_number] => 10012885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1138762 [patent_doc_number] => 06780842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent' [patent_app_type] => B2 [patent_app_number] => 10/012730 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13788 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780842.pdf [firstpage_image] =>[orig_patent_app_number] => 10012730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6161772 [patent_doc_number] => 20020147999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Methods of treating disorders related to apoE' [patent_app_type] => new [patent_app_number] => 10/033526 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23738 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147999.pdf [firstpage_image] =>[orig_patent_app_number] => 10033526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6689051 [patent_doc_number] => 20030032776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1' [patent_app_type] => new [patent_app_number] => 10/040805 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 109066 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032776.pdf [firstpage_image] =>[orig_patent_app_number] => 10040805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968041 [patent_doc_number] => 20020090655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Method of purification of neuropeptide containing vesicles from the brain' [patent_app_type] => new [patent_app_number] => 10/001898 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8794 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090655.pdf [firstpage_image] =>[orig_patent_app_number] => 10001898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253083 [patent_doc_number] => 06670138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Method of diagnosing ischemic stroke via UCP-2 detection' [patent_app_type] => B2 [patent_app_number] => 10/001051 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 25220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670138.pdf [firstpage_image] =>[orig_patent_app_number] => 10001051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307787 [patent_doc_number] => 20020094948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron' [patent_app_type] => new [patent_app_number] => 10/047749 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6489 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094948.pdf [firstpage_image] =>[orig_patent_app_number] => 10047749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164652 [patent_doc_number] => 06756215 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Functionalized TGF- fusion proteins' [patent_app_type] => B1 [patent_app_number] => 10/017372 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 42380 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756215.pdf [firstpage_image] =>[orig_patent_app_number] => 10017372 [rel_patent_id] =>[rel_patent_doc_number] =>)